Liquid-liquid phase separation of RBM33 facilitates hippocampus aging by inducing microglial senescence by activating

Xiaowen Yang1, Lin Wei2, Saifeng Zhong3

  • 1Department of Clinical Laboratory, Taihe Hospital, The Affiliated Hospital of Hubei University of Medicine, Shiyan 442000, China; Department of Clinical Laboratory, Hunan Provincial People's Hospital, The First-Affiliated Hospital of Hunan Normal University/Department of Laboratory Medicine of School of Medicine, Hunan Normal University, Changsha 410000, China; Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China.

Insights

RNA-binding protein 33 (RBM33) promotes brain aging by inducing microglial senescence, impairing hippocampus-dependent memory. Targeting the RBM33/p21 axis may combat cognitive decline and brain aging.

Area of Science:

  • Neuroscience
  • Aging Research
  • Molecular Biology

Background:

  • Microglia are crucial for hippocampus-dependent memory and cognitive function.
  • Microglial aging contributes to brain aging and neurodegenerative diseases, but mechanisms are unclear.
  • RNA-binding protein 33 (RBM33) is implicated in aging processes.

Purpose of the Study:

  • To investigate the role of RBM33 in hippocampal aging and cognitive decline.
  • To elucidate the molecular mechanisms by which RBM33 influences microglial senescence and brain aging.

Main Methods:

  • Analysis of RBM33 expression in aged mice and senescent microglia.
  • Genetic manipulation of RBM33 in the hippocampus (knockout and overexpression models).
  • Investigation of RBM33 liquid-liquid phase separation (LLPS) and its interaction with the CDKN1A (p21) promoter.

Main Results:

  • RBM33 expression is elevated in aged hippocampus and senescent microglia.
  • Hippocampal RBM33 deletion alleviates age-related memory deficits, while overexpression exacerbates them.
  • RBM33 LLPS drives microglial senescence via non-canonical regulation of the p21 promoter, impairing cognitive function.

Conclusions:

  • RBM33 acts as an age-promoting factor in the hippocampus by inducing microglial senescence.
  • The RBM33 LLPS/p21 axis is a key driver of brain aging and cognitive decline.
  • Targeting the RBM33 LLPS/p21 axis offers a potential therapeutic strategy for age-related cognitive impairment.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...